Literature DB >> 31832870

Letter to the Editor re: "Semiquantitative Parameters in PSMA-Targeted PET Imaging with [18F]DCFPyL: Impact of Tumor Burden on Normal Organ Uptake".

Rudolf A Werner1,2, Kenneth J Pienta3, Martin G Pomper1,3, Michael A Gorin1,3, Steven P Rowe1,3, Martin A Lodge1, Ralph A Bundschuh4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 31832870     DOI： 10.1007/s11307-019-01452-0

Source DB:  PubMed          Journal:  Mol Imaging Biol        ISSN： 1536-1632            Impact factor:   3.488


× No keyword cloud information.
  15 in total

1.  Semiquantitative Parameters in PSMA-Targeted PET Imaging with [18F]DCFPyL: Intrapatient and Interpatient Variability of Normal Organ Uptake.

Authors:  Karine Sahakyan; Xin Li; Martin A Lodge; Rudolf A Werner; Ralph A Bundschuh; Lena Bundschuh; Harshad R Kulkarni; Christiane Schuchardt; Richard P Baum; Kenneth J Pienta; Martin G Pomper; Ashley E Ross; Michael A Gorin; Steven P Rowe
Journal:  Mol Imaging Biol       Date:  2020-02       Impact factor: 3.488

2.  Letter to the Editor re: Semiquantitative Parameters in PSMA-Targeted PET Imaging with [18F]DCFPyL: Impact of Tumor Burden on Normal Organ Uptake.

Authors:  M C F Cysouw; B H E Jansen; M Yaqub; J Voortman; A N Vis; R J A van Moorselaar; O S Hoekstra; R Boellaard; D E Oprea-Lager
Journal:  Mol Imaging Biol       Date:  2020-02       Impact factor: 3.488

3.  Effects of Fasting on 18F-DCFPyL Uptake in Prostate Cancer Lesions and Tissues with Known High Physiologic Uptake.

Authors:  Maurits Wondergem; Friso M van der Zant; Peter W Vlottes; Remco J J Knol
Journal:  J Nucl Med       Date:  2018-03-01       Impact factor: 10.057

4.  German Multicenter Study Investigating 177Lu-PSMA-617 Radioligand Therapy in Advanced Prostate Cancer Patients.

Authors:  Kambiz Rahbar; Hojjat Ahmadzadehfar; Clemens Kratochwil; Uwe Haberkorn; Michael Schäfers; Markus Essler; Richard P Baum; Harshad R Kulkarni; Matthias Schmidt; Alexander Drzezga; Peter Bartenstein; Andreas Pfestroff; Markus Luster; Ulf Lützen; Marlies Marx; Vikas Prasad; Winfried Brenner; Alexander Heinzel; Felix M Mottaghy; Juri Ruf; Philipp Tobias Meyer; Martin Heuschkel; Maria Eveslage; Martin Bögemann; Wolfgang Peter Fendler; Bernd Joachim Krause
Journal:  J Nucl Med       Date:  2016-10-20       Impact factor: 10.057

5.  Tumor-to-blood ratio for assessment of somatostatin receptor density in neuroendocrine tumors using 68Ga-DOTATOC and 68Ga-DOTATATE.

Authors:  Ezgi Ilan; Irina Velikyan; Mattias Sandström; Anders Sundin; Mark Lubberink
Journal:  J Nucl Med       Date:  2019-07-13       Impact factor: 10.057

6.  Simplified Methods for Quantification of 18F-DCFPyL Uptake in Patients with Prostate Cancer.

Authors:  Bernard H E Jansen; Maqsood Yaqub; Jens Voortman; Matthijs C F Cysouw; Albert D Windhorst; Robert C Schuit; Gerbrand M Kramer; Alfons J M van den Eertwegh; Lothar A Schwarte; N Harry Hendrikse; André N Vis; Reindert J A van Moorselaar; Otto S Hoekstra; Ronald Boellaard; Daniela E Oprea-Lager
Journal:  J Nucl Med       Date:  2019-04-18       Impact factor: 10.057

7.  Measuring response to therapy using FDG PET: semi-quantitative and full kinetic analysis.

Authors:  Patsuree Cheebsumon; Linda M Velasquez; Corneline J Hoekstra; Wendy Hayes; Reina W Kloet; Nikie J Hoetjes; Egbert F Smit; Otto S Hoekstra; Adriaan A Lammertsma; Ronald Boellaard
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-01-06       Impact factor: 9.236

8.  Prospective Evaluation of PSMA-Targeted 18F-DCFPyL PET/CT in Men with Biochemical Failure After Radical Prostatectomy for Prostate Cancer.

Authors:  Steven P Rowe; Scott P Campbell; Margarita Mana-Ay; Zsolt Szabo; Mohamad E Allaf; Kenneth J Pienta; Martin G Pomper; Ashley E Ross; Michael A Gorin
Journal:  J Nucl Med       Date:  2019-06-14       Impact factor: 11.082

9.  A phase II randomized trial of Observation versus stereotactic ablative RadiatIon for OLigometastatic prostate CancEr (ORIOLE).

Authors:  Noura Radwan; Ryan Phillips; Ashley Ross; Steven P Rowe; Michael A Gorin; Emmanuel S Antonarakis; Curtiland Deville; Stephen Greco; Samuel Denmeade; Channing Paller; Daniel Y Song; Maximilian Diehn; Hao Wang; Michael Carducci; Kenneth J Pienta; Martin G Pomper; Theodore L DeWeese; Adam Dicker; Mario Eisenberger; Phuoc T Tran
Journal:  BMC Cancer       Date:  2017-06-29       Impact factor: 4.430

10.  225Ac-PSMA-617 in chemotherapy-naive patients with advanced prostate cancer: a pilot study.

Authors:  Mike Sathekge; Frank Bruchertseifer; Otto Knoesen; Florette Reyneke; Ismaheel Lawal; Thabo Lengana; Cindy Davis; Johncy Mahapane; Ceceila Corbett; Mariza Vorster; Alfred Morgenstern
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-09-19       Impact factor: 9.236
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.